Susquehanna International Group, LLP Ascendis Pharma A/S Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Susquehanna International Group, LLP holds 29,860 shares of ASND stock, worth $4.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,860

Previous 2,006 1388.53%

Holding current value

$4.57 Million

Previous $299,000 1274.58%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$122.0 - $146.6 $3.4 Million - $4.08 Million	27,854 Added 1388.53%	29,860 $4.11 Million
Q3 2024 Nov 14, 2024	SELL	$113.0 - $153.43 $486,691 - $660,823	-4,307 Reduced 68.22%	2,006 $299,000
Q2 2024 Aug 15, 2024	BUY	$121.07 - $153.67 $764,314 - $970,118	6,313 New	6,313 $860,000
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $406,204 - $488,243	4,696 Added 32.09%	19,330 $1.81 Million
Q2 2023 Aug 11, 2023	BUY	$69.96 - $97.84 $1.02 Million - $1.43 Million	14,634 New	14,634 $1.31 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $3.82 Million - $5.07 Million	-38,381 Reduced 84.42%	7,081 $864,000
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $3.82 Million - $5.01 Million	45,462 New	45,462 $4.69 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $1.03 Million - $1.37 Million	10,092 Added 38.09%	36,587 $4.29 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $2.53 Million - $3.38 Million	19,920 Added 302.97%	26,495 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $1.69 Million - $2.66 Million	-15,043 Reduced 69.59%	6,575 $1.05 Million
Q2 2021 Aug 11, 2021	BUY	$121.62 - $145.29 $1.53 Million - $1.83 Million	12,592 Added 139.51%	21,618 $2.84 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $937,899 - $1.3 Million	-7,508 Reduced 45.41%	9,026 $1.16 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $812,397 - $981,969	-5,373 Reduced 24.53%	16,534 $2.76 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $2.49 Million - $2.86 Million	18,520 Added 546.8%	21,907 $3.38 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $22,063 - $31,045	199 Added 6.24%	3,387 $501,000
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $17 Million - $25.4 Million	-174,973 Reduced 98.21%	3,188 $359,000
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $417,194 - $634,665	-4,562 Reduced 2.5%	178,161 $24.8 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $10.4 Million - $12.9 Million	108,876 Added 147.43%	182,723 $17.6 Million
Q2 2019 Aug 16, 2019	BUY	$107.11 - $132.09 $346,500 - $427,311	3,235 Added 4.58%	73,847 $8.5 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $6.62 Million - $8.17 Million	-61,830 Reduced 46.68%	70,612 $8.13 Million
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $5.43 Million - $6.49 Million	-85,103 Reduced 39.12%	132,442 $9.39 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $12.7 Million - $16.1 Million	217,545 New	217,545 $14.5 Million

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.55B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Ascendis Pharma A/S Transaction History